InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Browse the full record of transactions filed by Versant Venture Capital VI, L.P.. Director active across 7 companies, notably LENZ Therapeutics, Inc.. In total, 24 reports have been recorded. Total volume traded: €13.7m. The latest transaction was filed on 30 September 2025 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations24 total
US$2m49,701 shares@ US$38.64630.38% mcap73.1% of flow
Common Stock
SEC:0001193125-25-228493·
€2m49,701 shares@ €38.64630.38% mcap36.6% of flow
Common Stock
SEC:0001193125-25-228493:0·
US$397,406307,707 shares@ US$1.2915100.0% of flow
Common Stock
SEC:0001193125-25-207677·
€397,406307,707 shares@ €1.291550.0% of flow
Common Stock
SEC:0001193125-25-207677:0·
US$706,38520,493 shares@ US$34.46960.14% mcap26.9% of flow
Common Stock
SEC:0000950170-25-111529·
€706,38520,493 shares@ €34.46960.14% mcap13.4% of flow
Common Stock
SEC:0000950170-25-111529:0·
0178,996 shares0
Common Stock
SEC:0000899243-22-004169:0·
0178,996 shares0
Common Stock
SEC:0000899243-22-004169·
0200,213 shares0
Common Stock
SEC:0000899243-22-001360·
0200,213 shares0
Common Stock
SEC:0000899243-22-001360:0·
0371,004 shares0
Common Stock
SEC:0000899243-21-049938·
0371,004 shares0
Common Stock
SEC:0000899243-21-049938:0·
0200,213 shares0
Common Stock
SEC:0000899243-21-049594·
0200,213 shares0
Common Stock
SEC:0000899243-21-049594:0·
€4m303,614 shares@ €12.5993100.0% of flow
Common Stock
SEC:0000899243-21-040777·
€4m303,614 shares@ €12.599350.0% of flow
Common Stock
SEC:0000899243-21-040777:0·
12,343,727 shares
Common Stock
SEC:0000899243-21-027018:0·
12,343,727 shares
Common Stock
SEC:0000899243-21-027018·
6,515,869 shares
Common Stock
SEC:0000899243-21-026766·
6,515,869 shares
Common Stock
SEC:0000899243-21-026766:0·
9,936,011 shares
Common Stock
SEC:0001104659-21-084643·
9,936,011 shares
Common Stock
SEC:0001104659-21-084643:0·
0320,340 shares0
Common Stock
SEC:0000899243-21-019515·
0320,340 shares0
Common Stock
SEC:0000899243-21-019515:0·
24 of 24 declarations
About Versant Venture Capital VI, L.P.
Versant Venture Capital VI, L.P. is an investor in LENZ Therapeutics, Inc.
